Global Scans · Cancer · Weekly Summary

• [New] The number of cancer cases is projected to reach 34 million by 2050, a 67% increase from 2024, solely based on population ageing and growth. American Cancer Society MediaRoom
• [New] To determine whether the DELFI approach could reliably detect liver cancer regardless of its underlying cause, investigators analyzed blood samples from 377 people from Guatemala and Romania, with and without hepatocellular carcinoma, the most common form of liver cancer. News-Medical
• [New] The FDA's acceptance of the BLA reinforces the important role that ifinatamab deruxtecan could play in helping to address the needs of patients with extensive-stage small cell lung cancer. DSI
• [New] Under new Medicare arrangements, patients with thyroid cancer will be able to undergo genetic testing to identify mutations in the RET gene, to confirm eligibility for treatment with Retevmo. Mirage News
• [New] Researchers have identified a blood signature that can predict lung cancer risk years before diagnosis - significant findings that could enhance prevention strategies for Australia's biggest cancer killer. WEHI
• [New] The phase 3 PROTEUS trial evaluated whether adding apalutamide to androgen deprivation therapy (ADT) before and after radical prostatectomy could improve outcomes for patients with high-risk localized or locally advanced prostate cancer. Journal of Oncology Navigation & Survivorship
• [New] The findings from UBC researchers could aid in earlier cancer detection by identifying at-risk families. Science Canada
• Along with age, smoking status and previous history of lung disease, the machine learning algorithm identified 14 key proteins in the blood that could predict a future diagnosis of lung cancer within five years. WEHI
• Landmark study co-led by the Crick Institute and UCL identifies a 14-protein blood signature that can predict lung cancer risk more than five years before diagnosis. WEHI
• In a population-based case-control study in Shanghai, China, consumption of green tea was associated with a reduced risk of lung cancer among non-smoking women and the risk decreased with increasing consumption. PubMed Central (PMC)
• Researchers at NYU Grossman School of Medicine and NYU's Center for Data Science developed a multimodal artificial intelligence test that may predict breast cancer recurrence faster and more affordably than current genomic assays. NYU Langone News
• Sustained reductions in mortality for CRC, the second-most common cause of cancer death in men and women combined, are the result of changing patterns in risk factors (e.g., declines in smoking), screening uptake, and improved treatment. Ovid
• J&J has openly said it wants to become the world's top cancer drugmaker by 2030, targeting $50 billion in oncology revenue by then. TU News
• The integration of algorithmic screening tools in mammography and lung cancer screening programs has demonstrated the potential to increase early detection rates by up to 15% compared to conventional methods alone. Market Data Forecast
• About 1 in 9 men and 1 in 13 women are expected to die from cancer, while annual cases are projected to reach 34 million by 2050, a 67% increase driven solely by population growth and ageing. SciTechDaily

Last updated: 16 August 2026